The ACOG guidelines recommend exercise and dietary change to reduce risk of diabetes; insulin-sensitizing agents to reduce androgen levels, improve ovulation, and improve glucose tolerance; and letrozole for ovulation induction.9 The OB/GYNs in our study frequently recommended all of the above treatments for their patients with PCOS and obesity. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.